Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
J Am Coll Cardiol
    March 2024
  1. QUINN R, Leader N, Lebovic G, Chow CM, et al
    Accuracy of Wearable Heart Rate Monitors During Exercise in Sinus Rhythm and Atrial Fibrillation.
    J Am Coll Cardiol. 2024;83:1177-1179.
    >> Share

  2. NINNI S, Dombrowicz D, de Winther M, Staels B, et al
    Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1163-1176.
    >> Share

  3. DIXIT S, Oranefo JU, Raad M
    Atrial Fibrillation Management With Antiarrhythmic Drug Therapy: Balancing Benefits and Bradycardia Risks.
    J Am Coll Cardiol. 2024;83:1039-1041.
    >> Share

  4. KIM YG, Lee HS, Kim H, Kim M, et al
    Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2024;83:1027-1038.
    >> Share

  5. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
    Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:932-950.
    >> Share

    February 2024
  6. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    >> Share

  7. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    >> Share

  8. ANDREOTTI F, Massetti M, Montalescot G
    Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition.
    J Am Coll Cardiol. 2024;83:679-681.
    >> Share

  9. EIKELBOOM JW, Mundl H, Alexander JH, Caso V, et al
    Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
    J Am Coll Cardiol. 2024;83:669-678.
    >> Share

    January 2024
  10. BEJJANI A, Khairani CD, Assi A, Piazza G, et al
    When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:444-465.
    >> Share

  11. DI BIASE L, Lakkireddy DJ, Marazzato J, Velasco A, et al
    Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:82-108.
    >> Share

    December 2023
  12. MULLEN CA
    Apixaban for Children With Heart Disease.
    J Am Coll Cardiol. 2023;82:2310-2311.
    >> Share

    November 2023
  13. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2023 Nov 30:S0735-1097(23)06465.
    >> Share

  14. WIGGINS BS, Cibotti-Sun M, Moore MM
    2023 Atrial Fibrillation Guideline-at-a-Glance.
    J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)07853.
    >> Share

  15. QIAN F, Siscovick D
    Reply: Omega-3 Fatty Acids and Atrial Fibrillation: The Importance of the Clinical Question.
    J Am Coll Cardiol. 2023;82:e207.
    >> Share

  16. MYHRE PL
    Omega-3 Fatty Acids and Atrial Fibrillation: The Difference Between Dietary Consumption and Supplementation.
    J Am Coll Cardiol. 2023;82:e205.
    >> Share

  17. CHEN H, Xu Y
    Omega-3 Fatty Acids and Atrial Fibrillation Risk: A Controversy Resolved?
    J Am Coll Cardiol. 2023;82:e203.
    >> Share

  18. O'KEEFE EL, Lavie CJ, Elagizi A, Milani RV, et al
    Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:e201-e202.
    >> Share

  19. SUN G, Ahlehoff O, Fosbol EL, Schou M, et al
    Long-Term Incidence of Atrial Fibrillation in Patients With Autoimmune Disease.
    J Am Coll Cardiol. 2023;82:1969-1971.
    >> Share

  20. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    >> Share

  21. SARNHOLM J, Ljotsson B, Braunschweig F
    Reply: Targeting Symptom Preoccupation in Atrial Fibrillation: A Promising Treatment Approach and Avenue for Future Research.
    J Am Coll Cardiol. 2023;82:e183-e184.
    >> Share

  22. ANDERSSON P, Coyne J
    Caution Warranted Regarding the Efficacy of iCBT in Patients With Symptomatic Paroxysmal Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e181.
    >> Share

  23. WANG J, Jia R, Lu Y, Yu W, et al
    Postmenopausal Women With Atrial Fibrillation and Mental Health Symptoms: A Group Deserving Attention.
    J Am Coll Cardiol. 2023;82:e179.
    >> Share

  24. DESAI BOSTROM AE, Lundberg J
    Beyond the Surface: Scrutinizing Methodological Biases in a Study on iCBT for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e177.
    >> Share

    October 2023
  25. MARGOLIS G, Chee J, Kazatsker M, Roguin A, et al
    Etiology of Early-Onset Complete Atrioventricular Block and Use of Implanted Cardiac Electronic Devices.
    J Am Coll Cardiol. 2023;82:1804-1806.
    >> Share

  26. HALPERIN JL, Rothman KJ
    Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving Target.
    J Am Coll Cardiol. 2023;82:1774-1776.
    >> Share

  27. KASKI JP, Norrish G
    Family Screening in Gene-Elusive Hypertrophic Cardiomyopathy: Time for a Change or Should We Tread Cautiously?
    J Am Coll Cardiol. 2023;82:1762-1764.
    >> Share

  28. CARVALHO PEP, Gewehr DM, Miyawaki IA, Nogueira A, et al
    Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2023;82:1765-1773.
    >> Share

  29. KRANTZ MJ, Stockbridge N, Kao DP, Klein MG, et al
    Reply: Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e159.
    >> Share

  30. FONT J, Alexandre J, Dolladille C, Milliez P, et al
    Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e157-e158.
    >> Share

  31. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    >> Share

    September 2023
  32. BESSIERE F, Waldmann V, Combes N, Metton O, et al
    Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1121-1130.
    >> Share

  33. BESSIERE F, Waldmann V, Combes N, Metton O, et al
    Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1108-1120.
    >> Share

  34. PUJOL-LOPEZ M, Du Fay de Lavallaz J, Rangan P, Beaser A, et al
    Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis.
    J Am Coll Cardiol. 2023;82:1096-1105.
    >> Share

  35. D'AVILA A, D'Angelo RN
    Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Atropine to the Rescue.
    J Am Coll Cardiol. 2023;82:1106-1107.
    >> Share

  36. SCHWENNESEN HT, Andrade JG, Wood KA, Piccini JP, et al
    Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:1039-1050.
    >> Share

    August 2023
  37. KIRKELS FP, van Osta N, Rootwelt-Norberg C, Chivulescu M, et al
    Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum.
    J Am Coll Cardiol. 2023;82:785-797.
    >> Share

  38. WESSELS JN, van Wezenbeek J, de Rover J, Smal R, et al
    Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis.
    J Am Coll Cardiol. 2023;82:704-717.
    >> Share

  39. MARTINEZ KA, Bos JM, Baggish AL, Phelan DM, et al
    Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death.
    J Am Coll Cardiol. 2023;82:661-670.
    >> Share

  40. WALDMANN V, Marquie C, Bessiere F, Perrot D, et al
    Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2023;82:590-599.
    >> Share

  41. BASKAR S, Czosek RJ, Spar DS
    A Look Beyond the Sports Field: A Paradigm of Shared Decision Making in Everyday Life.
    J Am Coll Cardiol. 2023;82:612-614.
    >> Share

  42. NEVES R, Bains S, Bos JM, MacIntyre CJ, et al
    Fatal Cardiac Arrhythmias During Electronic Gaming in Patients With Genetically Mediated Heart Diseases.
    J Am Coll Cardiol. 2023;82:603-611.
    >> Share

  43. SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al
    First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With Advanced Heart Failure Undergoing VT Ablation.
    J Am Coll Cardiol. 2023;82:469-471.
    >> Share

  44. STEINBERG JS, Kutyifa V
    Long-Term Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator System.
    J Am Coll Cardiol. 2023;82:398-400.
    >> Share

  45. GOLD MR, El-Chami MF, Burke MC, Upadhyay GA, et al
    Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    J Am Coll Cardiol. 2023;82:383-397.
    >> Share

    July 2023
  46. DENG W, Mansour M, Song B, Hou H, et al
    Fall Outcomes With Left Atrial Appendage Occlusion vs Direct Oral Anticoagulants for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:379-381.
    >> Share

  47. MARON BJ, Estes NAM, Rowin EJ, Maron MS, et al
    Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
    J Am Coll Cardiol. 2023;82:353-373.
    >> Share

  48. BALLANTYNE CM, Jia X
    Omega-3 Fatty Acids and Risk for Atrial Fibrillation: Big Fish or Small Fry?
    J Am Coll Cardiol. 2023;82:350-352.
    >> Share

  49. QIAN F, Tintle N, Jensen PN, Lemaitre RN, et al
    Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:336-349.
    >> Share

  50. FITZGIBBONS TP
    Epicardial Adipose-Derived miR92a-3p: Stress Reduction Therapy?
    J Am Coll Cardiol. 2023;82:333-335.
    >> Share

  51. BURCZAK DR, Julakanti RR, Kara Balla A, Scott CG, et al
    Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:278-279.
    >> Share

  52. MCCABE PJ
    Beyond Drugs and Ablation: New Hope for Symptom Management in Patients With Paroxysmal Atrial Fibrillation?
    J Am Coll Cardiol. 2023;82:57-59.
    >> Share

  53. SARNHOLM J, Skuladottir H, Ruck C, Axelsson E, et al
    Cognitive Behavioral Therapy Improves Quality of Life in Patients With Symptomatic Paroxysmal Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:46-56.
    >> Share

    June 2023
  54. TURNBULL S, Garikapati K, Bennett RG, Campbell TG, et al
    Utility of a Handheld, Single-Lead ECG Device for Diagnosis of Cardiac Arrhythmias.
    J Am Coll Cardiol. 2023;81:2292-2294.
    >> Share

  55. KRANTZ MJ, Rudo TJ, Haigney MCP, Stockbridge N, et al
    Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids.
    J Am Coll Cardiol. 2023;81:2258-2268.
    >> Share

  56. JENTZER JC, Noseworthy PA, Kashou AH, May AM, et al
    Multidisciplinary Critical Care Management of Electrical Storm: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:2189-2206.
    >> Share

    May 2023
  57. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    >> Share

  58. FERRICK KJ
    Atrial Fibrillation Ablation: Safety in Numbers.
    J Am Coll Cardiol. 2023;81:2100-2102.
    >> Share

  59. BENALI K, Khairy P, Hammache N, Petzl A, et al
    Procedure-Related Complications of Catheter Ablation for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:2089-2099.
    >> Share

  60. BOKMA JP, Geva T, Sleeper LA, Lee JH, et al
    Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.
    J Am Coll Cardiol. 2023;81:2075-2085.
    >> Share

  61. MULLER SA, Gasperetti A, Bosman LP, Schmidt AF, et al
    Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2023 May 9:S0735-1097(23)05543.
    >> Share

    April 2023
  62. PATLOLLA SH, Schaff HV
    Reply: Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
    J Am Coll Cardiol. 2023;81:e141.
    >> Share

  63. BONAPACE S, Marinelli A, Costa A, Trachanas K, et al
    Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
    J Am Coll Cardiol. 2023;81:e139.
    >> Share

  64. MALLAT Z
    Fishing CHIPs to Predict Postoperative Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:1279-1282.
    >> Share

  65. NINNI S, Dombrowicz D, Kuznetsova T, Vicario R, et al
    Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation.
    J Am Coll Cardiol. 2023;81:1263-1278.
    >> Share

    March 2023
  66. HUIZAR JF, Kaszala K, Tan A, Koneru J, et al
    Abnormal Conduction-Induced Cardiomyopathy: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1192-1200.
    >> Share

  67. ALKHOULI M, Di Biase L, Natale A, Rihal CS, et al
    Nonthrombogenic Roles of the Left Atrial Appendage: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1063-1075.
    >> Share

  68. DEWITT E, Etheridge SP
    Sudden Cardiac Death in Adolescents: Allowing the Dead to Speak.
    J Am Coll Cardiol. 2023;81:1018-1020.
    >> Share

  69. FINOCCHIARO G, Radaelli D, D'Errico S, Papadakis M, et al
    Sudden Cardiac Death Among Adolescents in the United Kingdom.
    J Am Coll Cardiol. 2023;81:1007-1017.
    >> Share

  70. GONZALEZ-CALLE D, Laffond A, Lopez-Tejero S, Sanchez PL, et al
    Impact of Peridevice Leak Outcomes After Left Atrial Appendage Closure: Does Size No Longer Matter?
    J Am Coll Cardiol. 2023;81:e79.
    >> Share

  71. NARAYAN SM, Rogers AJ
    Can Machine Learning Disrupt the Prediction of Sudden Death?
    J Am Coll Cardiol. 2023;81:962-963.
    >> Share

  72. GINDER C, Li J, Halperin JL, Akar JG, et al
    Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring.
    J Am Coll Cardiol. 2023;81:949-961.
    >> Share

  73. REYNOLDS MR, Ahmad J
    The NCDR AFib Ablation Registry: Better Late Than Never?
    J Am Coll Cardiol. 2023;81:879-881.
    >> Share

  74. HSU JC, Darden D, Du C, Marine JE, et al
    Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures.
    J Am Coll Cardiol. 2023;81:867-878.
    >> Share

    February 2023
  75. VAN GELDER IC, Ekrami NK, Borof K, Fetsch T, et al
    Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial.
    J Am Coll Cardiol. 2023;81:845-847.
    >> Share

  76. GERGES C, Pistritto AM, Gerges M, Friewald R, et al
    Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;81:653-664.
    >> Share

  77. BISLERI G, Pandey AK, Verma S, Ali Hassan SM, et al
    Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:606-619.
    >> Share

  78. WILDE AAM, Schwartz PJ
    Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers.
    J Am Coll Cardiol. 2023;81:487-489.
    >> Share

  79. BAINS S, Neves R, Bos JM, Giudicessi JR, et al
    Phenotypes of Overdiagnosed Long QT Syndrome.
    J Am Coll Cardiol. 2023;81:477-486.
    >> Share

    January 2023
  80. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    >> Share

    December 2022
  81. RUF TF, Gossler TAM, von Bardeleben RS
    Understanding Atrial Fibrillation and Atrial Secondary Tricuspid Regurgitation: The Chicken or the Egg?
    J Am Coll Cardiol. 2022;80:2299-2300.
    >> Share

  82. PATLOLLA SH, Schaff HV, Nishimura RA, Stulak JM, et al
    Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:2289-2298.
    >> Share

  83. FARHAN S, Silbiger JJ, Halperin JL, Zhang L, et al
    Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2314-2330.
    >> Share

  84. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
    Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2224-2238.
    >> Share

  85. VOIGT N, Maack C, Pronto JRD
    Targeting Mitochondrial Calcium Handling to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:2220-2223.
    >> Share

  86. FOSSIER L, Panel M, Butruille L, Colombani S, et al
    Enhanced Mitochondrial Calcium Uptake Suppresses Atrial Fibrillation Associated With Metabolic Syndrome.
    J Am Coll Cardiol. 2022;80:2205-2219.
    >> Share

    November 2022
  87. ISBISTER JC, Nowak N, Yeates L, Singer ES, et al
    Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for Families.
    J Am Coll Cardiol. 2022;80:2057-2068.
    >> Share

  88. PALDINO A, Dal Ferro M, Stolfo D, Gandin I, et al
    Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.
    J Am Coll Cardiol. 2022;80:1981-1994.
    >> Share

  89. SIEIRA J, Stroker E, Bala G, Overeinder I, et al
    Brugada Syndrome During Infancy and Childhood: 30 Years' Experience.
    J Am Coll Cardiol. 2022;80:1961-1962.
    >> Share

    October 2022
  90. WALDMANN V, Marquie C, Bouzeman A, Duthoit G, et al
    Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.
    J Am Coll Cardiol. 2022;80:1701-1703.
    >> Share

  91. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    >> Share

  92. LA GERCHE A, Wasfy MM, Brosnan MJ, Claessen G, et al
    The Athlete's Heart-Challenges and Controversies: JACC Focus Seminar 4/4.
    J Am Coll Cardiol. 2022;80:1346-1362.
    >> Share

    September 2022
  93. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    >> Share

  94. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    >> Share

  95. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    >> Share

  96. KANTER RJ
    Care of the Infant With Supraventricular Tachycardia: Toward a Better Paradigm.
    J Am Coll Cardiol. 2022;80:1173-1176.
    >> Share

  97. MOORE JA, Stephens SB, Kertesz NJ, Evans DL, et al
    Clinical Predictors of Recurrent Supraventricular Tachycardia in Infancy.
    J Am Coll Cardiol. 2022;80:1159-1172.
    >> Share

  98. TZOU WS
    Insights From the Dilated Cardiomyopathy Ventricular Tachycardia Ablation Study: Wisdom Through Humility.
    J Am Coll Cardiol. 2022;80:1057-1059.
    >> Share

  99. ZEPPENFELD K, Wijnmaalen AP, Ebert M, Baldinger SH, et al
    Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;80:1045-1056.
    >> Share

  100. BENALI K, Martins RP, Guenancia C, Da Costa A, et al
    Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
    J Am Coll Cardiol. 2022;80:e77.
    >> Share

  101. ARENAL A, Avila P
    Reply: Survive the Threat of Slow VT.
    J Am Coll Cardiol. 2022;80:e79-e80.
    >> Share

  102. REIFFEL JA
    Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome.
    J Am Coll Cardiol. 2022;80:e75.
    >> Share

    August 2022
  103. CORBALAN R, Acevedo M
    Glifozins and Atrial Fibrillation.
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
    >> Share

  104. MOHAMMADI-SHEMIRANI P, Chong M, Pare G
    Reply: Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e51.
    >> Share

  105. HEGELE RA
    Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e49-e50.
    >> Share

  106. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
    Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
    J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
    >> Share

  107. SCHMIDT B, Chun KRJ
    Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis.
    J Am Coll Cardiol. 2022;80:484-485.
    >> Share

  108. DUKKIPATI SR, Holmes DR Jr, Doshi SK, Kar S, et al
    Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2022;80:469-483.
    >> Share

    July 2022
  109. SVENNBERG E
    How to Treat Patients With First-Diagnosed Atrial Fibrillation: The Less Clear Pattern?
    J Am Coll Cardiol. 2022;80:296-298.
    >> Share

  110. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
    Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
    J Am Coll Cardiol. 2022;80:283-295.
    >> Share

  111. DE BACKER J, Narula J
    Cardiolaminopathies: Weighing in on the Concept of Genotype-First Screening.
    J Am Coll Cardiol. 2022;80:60-62.
    >> Share

  112. LAZARTE J, Jurgens SJ, Choi SH, Khurshid S, et al
    LMNA Variants and Risk of Adult-Onset Cardiac Disease.
    J Am Coll Cardiol. 2022;80:50-59.
    >> Share

  113. SOLOW EB, Bermas BL
    Hydroxychloroquine: Heart-Throb No More?
    J Am Coll Cardiol. 2022;80:47-49.
    >> Share

    June 2022
  114. GAUDINO M, Di Franco A, Rong LQ, Cao D, et al
    Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2529-2539.
    >> Share

  115. CURTIS AB, Korada SKC
    Should Atrial Fibrillation Be Included in Preoperative Risk Assessment for Noncardiac Surgery?
    J Am Coll Cardiol. 2022;79:2486-2488.
    >> Share

  116. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    >> Share

  117. AHMED A, Pothineni NVK, Charate R, Garg J, et al
    Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2450-2462.
    >> Share

  118. TAKAHASHI T, Samuels BA, Li W, Parikh MA, et al
    Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
    J Am Coll Cardiol. 2022;79:2367-2378.
    >> Share

  119. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    >> Share

    May 2022
  120. RAJPAL S, Kahwash R, Tong MS, Paschke K, et al
    Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
    J Am Coll Cardiol. 2022;79:2144-2152.
    >> Share

  121. CAMM AJ, Naccarelli GV, Mittal S, Crijns HJGM, et al
    The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1932-1948.
    >> Share

  122. FREEMAN JV, Higgins AY, Wang Y, Du C, et al
    Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:1785-1798.
    >> Share

  123. HOLMES DR JR
    Antithrombotic Therapy After Left Atrial Appendage Occlusion: Cornucopia and Gertrude Stein.
    J Am Coll Cardiol. 2022;79:1799-1801.
    >> Share

    April 2022
  124. KIM DS, Khandelwal A
    Lipoprotein(a) and Incident Atrial Fibrillation: Leveraging Nature's Randomization to Identify Novel Causal Associations.
    J Am Coll Cardiol. 2022;79:1591-1593.
    >> Share

  125. MOHAMMADI-SHEMIRANI P, Chong M, Narula S, Perrot N, et al
    Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
    J Am Coll Cardiol. 2022;79:1579-1590.
    >> Share

  126. AMUTHAN R, Curtis AB
    Sex-Specific Considerations in Drug and Device Therapy of Cardiac Arrhythmias: JACC Focus Seminar 6/7.
    J Am Coll Cardiol. 2022;79:1519-1529.
    >> Share

  127. SALEEM M, Costanzo MR
    Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
    J Am Coll Cardiol. 2022;79:1454-1457.
    >> Share

  128. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    >> Share

  129. PICCINI JP, Harrington J
    Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?
    J Am Coll Cardiol. 2022;79:1382-1384.
    >> Share

  130. SCHWEIZER J, Arnold M, Konig IR, Bicvic A, et al
    Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
    J Am Coll Cardiol. 2022;79:1369-1381.
    >> Share

    March 2022
  131. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
    Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1199-1211.
    >> Share

  132. FRIEDMAN DJ, Qin L, Parzynski C, Heist EK, et al
    Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
    J Am Coll Cardiol. 2022;79:1050-1059.
    >> Share

  133. MARWICK TH, Brugger N
    Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
    J Am Coll Cardiol. 2022;79:962-964.
    >> Share

  134. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
    Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:951-961.
    >> Share

    February 2022
  135. ROMANOV A, Lomivorotov V, Chernyavskiy A, Murtazin V, et al
    Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes.
    J Am Coll Cardiol. 2022;79:754-756.
    >> Share

  136. ZAFEIROPOULOS S, Doundoulakis I, Farmakis IT, Miyara S, et al
    Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:682-694.
    >> Share

  137. LEYVA F, Zegard A, Okafor O, Foley P, et al
    Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.
    J Am Coll Cardiol. 2022;79:665-678.
    >> Share

  138. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    >> Share

  139. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    >> Share

    January 2022
  140. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    >> Share

  141. MERCHANT FM
    Does Percutaneous Left Atrial Appendage Closure Stand the Test of Time?
    J Am Coll Cardiol. 2022;79:15-17.
    >> Share

    December 2021
  142. NORBY FL, Benjamin EJ, Alonso A, Chugh SS, et al
    Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.
    J Am Coll Cardiol. 2021;78:2563-2572.
    >> Share

  143. SALMASI S, De Vera MA, Safari A, Lynd LD, et al
    Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:2395-2404.
    >> Share

  144. SAHA SA
    Premature Ventricular Complexes During Exercise in Asymptomatic Adults: Do They Deserve a Closer Look?
    J Am Coll Cardiol. 2021;78:2278-2280.
    >> Share

  145. REFAAT MM, Gharios C, Moorthy MV, Abdulhai F, et al
    Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.
    J Am Coll Cardiol. 2021;78:2267-2277.
    >> Share

    November 2021
  146. MARQUEZ MF
    The Quest for the Evidence of Effectiveness of Implantable Cardioverter-Defibrillators in Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2089-2091.
    >> Share

  147. WANG M, Peterson DR, Rosero S, McNitt S, et al
    Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2076-2088.
    >> Share

  148. TERTULIEN T, Magnani JW, Essien UR
    Racial and Ethnic Representation in Atrial Fibrillation Trials: CABANA and Beyond.
    J Am Coll Cardiol. 2021;78:e163-e164.
    >> Share

  149. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
    Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e159.
    >> Share

  150. WANG X, Wang P, Pei H
    Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e157.
    >> Share

    October 2021
  151. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.
    J Am Coll Cardiol. 2021 Oct 27. pii: S0735-1097(21)07895.
    >> Share

  152. ERNAULT AC, Meijborg VMF, Coronel R
    Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1730-1745.
    >> Share

  153. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
    Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1682-1699.
    >> Share

  154. BEHR ER
    J-Wave Syndromes, SCN5A, and Cardiac Conduction Reserve: Two Sides of the Same Coin?
    J Am Coll Cardiol. 2021;78:1618-1620.
    >> Share

  155. ZHANG ZH, Barajas-Martinez H, Xia H, Li B, et al
    Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    J Am Coll Cardiol. 2021;78:1603-1617.
    >> Share

  156. ASATRYAN B, Odening KE, Reichlin T
    Myocardial Histopathology Studies in Brugada Syndrome Decedents: Structural Features of a Presumed Electrical Disease.
    J Am Coll Cardiol. 2021;78:1522-1524.
    >> Share

  157. MILES C, Asimaki A, Ster IC, Papadakis M, et al
    Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2021;78:1511-1521.
    >> Share

    September 2021
  158. LURIE A, Wang J, Healey JS, Wong JA, et al
    Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:e91-e92.
    >> Share

  159. KADISH A, Jacobson J
    Sleep Patterns and Arrhythmias: Should This Keep Us Awake at Night?
    J Am Coll Cardiol. 2021;78:1208-1209.
    >> Share

  160. LI X, Zhou T, Ma H, Huang T, et al
    Healthy Sleep Patterns and Risk of Incident Arrhythmias.
    J Am Coll Cardiol. 2021;78:1197-1207.
    >> Share

    August 2021
  161. ANDRADE JG, Wazni OM, Kuniss M, Hawkins NM, et al
    Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:914-930.
    >> Share

  162. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
    Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
    J Am Coll Cardiol. 2021;78:643-662.
    >> Share

  163. BERG DD, Giugliano RP, Ruff CT, Tang M, et al
    A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.
    J Am Coll Cardiol. 2021;78:634-636.
    >> Share

    July 2021
  164. WAZNI O, Saliba W, Hussein AA
    Device-Related Thrombus After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:314-316.
    >> Share

  165. SIMARD T, Jung RG, Lehenbauer K, Piayda K, et al
    Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:297-313.
    >> Share

  166. THOMAS KL, Al-Khalidi HR, Silverstein AP, Monahan KH, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:126-138.
    >> Share

  167. RUSSO AM
    Catheter Ablation Is Better Than Drugs for Treatment of AF in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:139-141.
    >> Share

    June 2021
  168. GRANGER CB, Pokorney SD
    Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:3002-3004.
    >> Share

  169. DI MARCO A, Brown PF, Bradley J, Nucifora G, et al
    Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;77:2890-2905.
    >> Share

  170. LURIE A, Wang J, Hinnegan KJ, McIntyre WF, et al
    Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:2875-2886.
    >> Share

  171. KIRCHHOF P, Sinning C
    Thrombus or No Thrombus: Is That the Embolic Question?
    J Am Coll Cardiol. 2021;77:2887-2889.
    >> Share

  172. CHEN YC, Voskoboinik A, Gerche A, Marwick TH, et al
    Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2846-2864.
    >> Share

  173. TREVISAN F, Bertini M, Balla C, Pestelli G, et al
    Type 1 Brugada Pattern Is Associated With Echocardiography-Detected Delayed Right Ventricular Outflow Tract Contraction.
    J Am Coll Cardiol. 2021;77:2865-2867.
    >> Share

  174. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    >> Share

    May 2021
  175. TOBERT KE, Bos JM, Garmany R, Ackerman MJ, et al
    Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death.
    J Am Coll Cardiol. 2021 May 26. pii: S0735-1097(21)04779.
    >> Share

  176. AKTAS MK, Younis A, Zareba W, Kutyifa V, et al
    Survival After Implantable Cardioverter-Defibrillator Shocks.
    J Am Coll Cardiol. 2021;77:2453-2462.
    >> Share

  177. DEO R, Pothineni NVK
    The "Shocking" Reality of ICD Therapies.
    J Am Coll Cardiol. 2021;77:2463-2465.
    >> Share

  178. CHRISTENSEN AH, Nyholm BC, Vissing CR, Pietersen A, et al
    Natural History and Clinical Characteristics of the First 10 Danish Families With Familial ST-Depression Syndrome.
    J Am Coll Cardiol. 2021;77:2617-2619.
    >> Share

  179. PRIORI SG, Mazzanti A, Santiago DJ, Kukavica D, et al
    Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2021;77:2592-2612.
    >> Share

  180. GIUDICESSI JR, Ackerman MJ, Fatkin D, Kovacic JC, et al
    Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2021;77:2573-2591.
    >> Share

  181. NACCARELLI GV, Filippone EJ, Foy A
    Do Mineralcorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04967.
    >> Share

  182. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
    Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
    >> Share

    April 2021
  183. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    >> Share

    March 2021
  184. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
    Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:1344-1356.
    >> Share

  185. CALO L, Della Bona R, Martino A, Crescenzi C, et al
    Left Posterior Fascicular Block and Increased Risk of Sudden Cardiac Death in Young People.
    J Am Coll Cardiol. 2021;77:1143-1145.
    >> Share

    February 2021
  186. LYON AR, Citro R, Schneider B, Morel O, et al
    Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:902-921.
    >> Share

  187. COHEN MI, Khairy P, Zeppenfeld K, Van Hare GF, et al
    Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:761-771.
    >> Share

    January 2021
  188. ARAI AE, Bradley AJ, Sirajuddin A
    Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
    J Am Coll Cardiol. 2021;77:42-44.
    >> Share

  189. ZEGARD A, Okafor O, de Bono J, Kalla M, et al
    Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:29-41.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016